New markers in pelvic inflammatory disease

Shun Fa Yang, Tzu Fan Wu, Hsiu Ting Tsai, Long Yau Lin, Po Hui Wang

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Pelvic inflammatory disease (PID) is a common infection in women of reproductive age. However, diagnosis of PID can be difficult due to the wide variation in the symptoms and signs, ranging from subtle or mild symptoms to severe pain in the lower abdomen. Clinical diagnosis alone has only 87% sensitivity and 50% specificity. Therefore, identifying biological factors that are useful for early diagnosis and correlating their expression with the severity of PID could provide significant benefits to women suffering from PID. Pentraxin 3 (PTX3), E-cadherin, myeloperoxidase, stromal cell-derived factor 1 (SDF-1) and the matrix metalloproteinase-9 (MMP-9)/MMP-2 ratio are potential candidates for detecting PID reliably. As PID is often subtle, highly sensitive PID detection methods are needed to promote the prevention of severe sequelae. Growth arrest-specific 6 (Gas6), in combination with its soluble tyrosine kinase receptor, sAxl, could elevate the sensitivity to 92%, which was higher than all other markers tested. Moreover, PTX3, D-dimer and YKL-40 concentrations can predict the clinical course of PID. Although single nucleotide polymorphisms of biomarker genes are not associated with the development of PID, myeloperoxidase SNP 463 G/A and SDF-1 SNP 801 G/A may affect the aggravated expression of their biomarkers in PID.

Original languageEnglish
Pages (from-to)118-124
Number of pages7
JournalClinica Chimica Acta
Volume431
DOIs
Publication statusPublished - Apr 20 2014
Externally publishedYes

Fingerprint

Pelvic Inflammatory Disease
Single Nucleotide Polymorphism
Chemokine CXCL12
Biomarkers
Peroxidase
Gastrin-Secreting Cells
Matrix Metalloproteinase 9
Biological Factors
Receptor Protein-Tyrosine Kinases
Cadherins
Polymorphism
Matrix Metalloproteinases
Abdomen
Signs and Symptoms
Early Diagnosis
Nucleotides
Genes
Sensitivity and Specificity
Pain

Keywords

  • Biomarkers
  • Clinical course
  • Pelvic inflammatory disease
  • Prediction
  • Single nucleotide polymorphisms

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical
  • Medicine(all)

Cite this

New markers in pelvic inflammatory disease. / Yang, Shun Fa; Wu, Tzu Fan; Tsai, Hsiu Ting; Lin, Long Yau; Wang, Po Hui.

In: Clinica Chimica Acta, Vol. 431, 20.04.2014, p. 118-124.

Research output: Contribution to journalArticle

Yang, Shun Fa ; Wu, Tzu Fan ; Tsai, Hsiu Ting ; Lin, Long Yau ; Wang, Po Hui. / New markers in pelvic inflammatory disease. In: Clinica Chimica Acta. 2014 ; Vol. 431. pp. 118-124.
@article{5a4582ef1c9447489194d5a4b995d673,
title = "New markers in pelvic inflammatory disease",
abstract = "Pelvic inflammatory disease (PID) is a common infection in women of reproductive age. However, diagnosis of PID can be difficult due to the wide variation in the symptoms and signs, ranging from subtle or mild symptoms to severe pain in the lower abdomen. Clinical diagnosis alone has only 87{\%} sensitivity and 50{\%} specificity. Therefore, identifying biological factors that are useful for early diagnosis and correlating their expression with the severity of PID could provide significant benefits to women suffering from PID. Pentraxin 3 (PTX3), E-cadherin, myeloperoxidase, stromal cell-derived factor 1 (SDF-1) and the matrix metalloproteinase-9 (MMP-9)/MMP-2 ratio are potential candidates for detecting PID reliably. As PID is often subtle, highly sensitive PID detection methods are needed to promote the prevention of severe sequelae. Growth arrest-specific 6 (Gas6), in combination with its soluble tyrosine kinase receptor, sAxl, could elevate the sensitivity to 92{\%}, which was higher than all other markers tested. Moreover, PTX3, D-dimer and YKL-40 concentrations can predict the clinical course of PID. Although single nucleotide polymorphisms of biomarker genes are not associated with the development of PID, myeloperoxidase SNP 463 G/A and SDF-1 SNP 801 G/A may affect the aggravated expression of their biomarkers in PID.",
keywords = "Biomarkers, Clinical course, Pelvic inflammatory disease, Prediction, Single nucleotide polymorphisms",
author = "Yang, {Shun Fa} and Wu, {Tzu Fan} and Tsai, {Hsiu Ting} and Lin, {Long Yau} and Wang, {Po Hui}",
year = "2014",
month = "4",
day = "20",
doi = "10.1016/j.cca.2014.02.004",
language = "English",
volume = "431",
pages = "118--124",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",

}

TY - JOUR

T1 - New markers in pelvic inflammatory disease

AU - Yang, Shun Fa

AU - Wu, Tzu Fan

AU - Tsai, Hsiu Ting

AU - Lin, Long Yau

AU - Wang, Po Hui

PY - 2014/4/20

Y1 - 2014/4/20

N2 - Pelvic inflammatory disease (PID) is a common infection in women of reproductive age. However, diagnosis of PID can be difficult due to the wide variation in the symptoms and signs, ranging from subtle or mild symptoms to severe pain in the lower abdomen. Clinical diagnosis alone has only 87% sensitivity and 50% specificity. Therefore, identifying biological factors that are useful for early diagnosis and correlating their expression with the severity of PID could provide significant benefits to women suffering from PID. Pentraxin 3 (PTX3), E-cadherin, myeloperoxidase, stromal cell-derived factor 1 (SDF-1) and the matrix metalloproteinase-9 (MMP-9)/MMP-2 ratio are potential candidates for detecting PID reliably. As PID is often subtle, highly sensitive PID detection methods are needed to promote the prevention of severe sequelae. Growth arrest-specific 6 (Gas6), in combination with its soluble tyrosine kinase receptor, sAxl, could elevate the sensitivity to 92%, which was higher than all other markers tested. Moreover, PTX3, D-dimer and YKL-40 concentrations can predict the clinical course of PID. Although single nucleotide polymorphisms of biomarker genes are not associated with the development of PID, myeloperoxidase SNP 463 G/A and SDF-1 SNP 801 G/A may affect the aggravated expression of their biomarkers in PID.

AB - Pelvic inflammatory disease (PID) is a common infection in women of reproductive age. However, diagnosis of PID can be difficult due to the wide variation in the symptoms and signs, ranging from subtle or mild symptoms to severe pain in the lower abdomen. Clinical diagnosis alone has only 87% sensitivity and 50% specificity. Therefore, identifying biological factors that are useful for early diagnosis and correlating their expression with the severity of PID could provide significant benefits to women suffering from PID. Pentraxin 3 (PTX3), E-cadherin, myeloperoxidase, stromal cell-derived factor 1 (SDF-1) and the matrix metalloproteinase-9 (MMP-9)/MMP-2 ratio are potential candidates for detecting PID reliably. As PID is often subtle, highly sensitive PID detection methods are needed to promote the prevention of severe sequelae. Growth arrest-specific 6 (Gas6), in combination with its soluble tyrosine kinase receptor, sAxl, could elevate the sensitivity to 92%, which was higher than all other markers tested. Moreover, PTX3, D-dimer and YKL-40 concentrations can predict the clinical course of PID. Although single nucleotide polymorphisms of biomarker genes are not associated with the development of PID, myeloperoxidase SNP 463 G/A and SDF-1 SNP 801 G/A may affect the aggravated expression of their biomarkers in PID.

KW - Biomarkers

KW - Clinical course

KW - Pelvic inflammatory disease

KW - Prediction

KW - Single nucleotide polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=84894095530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894095530&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2014.02.004

DO - 10.1016/j.cca.2014.02.004

M3 - Article

C2 - 24525211

AN - SCOPUS:84894095530

VL - 431

SP - 118

EP - 124

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

ER -